Likewise, concurrent overexpression of CD38 and NAMPT inhibition had synergistic effect on growth suppression in pancreatic cancer (Chini et al., 2014), suggesting a critical dependence of cancers on NAD+ that may be explored therapeutically. The gene discussed is CD38; the disease is pancreatic neoplasm.